NCI-H82 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The NCI-H82 cell line was derived by A.F. Gazdar and associates in 1978 from the pleural fluid of a patient with small cell cancer of the lung. The morphology of the original tumor was not characteristic of SCLC. The line is a biochemical and morphological variant of SCLC that expresses neuron specific enolase and the brain isoenzyme of creatine kinase. It does not have detectable levels of L-DOPA decarboxylase or bombesin. The cells produce an abnormally sized p53 mRNA (3.7 kb). C-myc DNA sequences are amplified about 25 fold, and there is a 24 fold increase in c-myc RNA relative to normal cells. The cells are reported to express functional ANP receptors, but treatment with ANP does not alter their growth pattern. The cells stain positively for neurofilaments and vimentin. There is expression of v-fes, v-fms, Ha-ras, Ki-ras, N-ras and c-raf 1 mRNAs. |
|---|---|
| Organism | Human |
| Tissue | Lung |
| Disease | Lung small cell carcinoma |
| Metastatic site | Pleural effusion |
| Synonyms | NCI-H-82, H82, H-82, NCI H82, NCIH82, H82sclc |
Characteristics
| Age | 41 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Aggregates in suspension. The cells grow in very large aggregates, which are the only viable cell population in the culture. |
Regulatory Data
| Citation | NCI-H82 (Cytion catalog number 300442) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1591 |
Biomolecular Data
| Receptors expressed | Insulin-like growth factor II receptor (IGF II), atrial natriuretic peptide (ANP) |
|---|---|
| Protein expression | P53 positive |
| Isoenzymes | G6PD, B, PGM1, 1-2, PGM3, 1-2, ES-D, 1, Me-2, 1, AK-1, 1, GLO-1, 1, Phenotype Frequency Product = 0.0082 |
| Tumorigenic | Yes, forms transplantable tumors with non-typical SCLC histology in nude mice |
| Karyotype | This is a near triploid human cell line. The modal chromosome number is 58, occurring at 44% with polyploidy at 3%. Each cell had two copies of a normal x chromosome. The Y chromosome was not detected in Q banded preparations. |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| Certificate of Analysis | 22. Dec. 2025 | ||
| 300442-512 | Certificate of Analysis | 23. May. 2025 | 300442 |
-
Related products
Related products